+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

HIV Drugs Global Market Report 2024 - Product Thumbnail Image

HIV Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
HIV Drugs - Global Strategic Business Report - Product Thumbnail Image

HIV Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 164 Pages
  • Global
From
HIV Drugs Market Report by Drug Class, Distribution Channel, and Region 2024-2032 - Product Thumbnail Image

HIV Drugs Market Report by Drug Class, Distribution Channel, and Region 2024-2032

  • Report
  • July 2024
  • 142 Pages
  • Global
From
HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
North America HIV Drugs Market Report by Drug Class, Distribution Channel, and Country 2024-2032 - Product Thumbnail Image

North America HIV Drugs Market Report by Drug Class, Distribution Channel, and Country 2024-2032

  • Report
  • July 2024
  • 121 Pages
  • North America
From
Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2024 - Product Thumbnail Image

Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HIV Treatment Drugs Market in Africa 2024-2028 - Product Thumbnail Image

HIV Treatment Drugs Market in Africa 2024-2028

  • Report
  • July 2024
  • 162 Pages
  • Africa
From
HIV Drugs and Injectables Market Report 2024-2034 - Product Thumbnail Image

HIV Drugs and Injectables Market Report 2024-2034

  • Report
  • July 2024
  • 288 Pages
  • Global
From
Human Immunodeficiency Virus Therapeutics Market by Drug Class, End-User, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Human Immunodeficiency Virus Therapeutics Market by Drug Class, End-User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 190 Pages
  • Global
From
Anti-Retroviral Drugs Market by Drug Class:, Route of Administration, Application, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Anti-Retroviral Drugs Market by Drug Class:, Route of Administration, Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 192 Pages
  • Global
From
Etravirine Market by Product Type, Application, Distribution Channel, Patient Age Group - Global Forecast 2025-2030 - Product Thumbnail Image

Etravirine Market by Product Type, Application, Distribution Channel, Patient Age Group - Global Forecast 2025-2030

  • Report
  • October 2024
  • 192 Pages
  • Global
From
HIV Clinical Trials Market by Phase, Study Design, Type of Intervention, Participant, Sponsor - Global Forecast 2025-2030 - Product Thumbnail Image

HIV Clinical Trials Market by Phase, Study Design, Type of Intervention, Participant, Sponsor - Global Forecast 2025-2030

  • Report
  • October 2024
  • 192 Pages
  • Global
From
HIV Vaccines Market by Phase, Category, Antibodies, End Users - Global Forecast 2025-2030 - Product Thumbnail Image

HIV Vaccines Market by Phase, Category, Antibodies, End Users - Global Forecast 2025-2030

  • Report
  • October 2024
  • 195 Pages
  • Global
From
HIV or AIDS Diagnostics Market by Product Type, Test Type, End User - Global Forecast 2025-2030 - Product Thumbnail Image

HIV or AIDS Diagnostics Market by Product Type, Test Type, End User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 198 Pages
  • Global
From
Fusion Inhibitors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032 - Product Thumbnail Image

Fusion Inhibitors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032

  • Report
  • March 2024
  • 118 Pages
  • Global
From
Human Immunodeficiency Virus Type 1 Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Human Immunodeficiency Virus Type 1 Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
HIV-associated Lipodystrophy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

HIV-associated Lipodystrophy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
HIV-associated Lipodystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

HIV-associated Lipodystrophy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more